[628] USE OF LOW-DOSE PEGINTERFERON a-2a (40 kD) (PEGASYS®) TO TREAT HEPATITIS C-INFECTED END-STAGE RENAL DISEASE PATIENTS UNDERGOING HAEMODIALYSIS: INTERIM RESULTS FROM A RANDOMISED STUDY

Saved in:
Bibliographic Details
Title: [628] USE OF LOW-DOSE PEGINTERFERON a-2a (40 kD) (PEGASYS®) TO TREAT HEPATITIS C-INFECTED END-STAGE RENAL DISEASE PATIENTS UNDERGOING HAEMODIALYSIS: INTERIM RESULTS FROM A RANDOMISED STUDY
Authors: Peck-Radosavljevic, M., Boletis, J., Besisik, F., Lucia Ferra, M., Alric, L., Samuel, D., Messinger, D., Junker, H., Cheinquer, H.
Source: Journal of Hepatology. Apr2007, Vol. 46, pS237-S238. 0p.
Database: Academic Search Ultimate
Description
ISSN:01688278
DOI:10.1016/S0168-8278(07)62226-0